J&J, Bristol Myers lose challenges to US drug price negotiation program

Third teenager charged with second-degree murder | SaltWire #newsupdate #news #halifax #police - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.U.S.

The drugmakers did not immediately respond to requests for comment, though Bristol Myers has already filed a notice in court that it was appealing the ruling. Drugmakers have argued that it is not feasible to withdraw from Medicare because it represents nearly half the U.S. prescription drug market. Eliquis brought Bristol Myers about $8.52 billion in U.S. sales last year, while J&J recorded $2.36 billion in Xarelto sales. Eliquis is shared with Pfizer and Xarelto with Bayer, which were not part of the lawsuits.

A Delaware federal judge last month rejected a challenge to the program by British drugmaker AstraZeneca. An Ohio federal judge in September rebuffed another lawsuit by the U.S. Chamber of Commerce, the nation's largest business lobbying group.

Canada Latest News, Canada Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Bristol Myers' schizophrenia drug reduces symptoms without weight gain in late-stage studiesExplore stories from Atlantic Canada.
Source: SaltWire Network - 🏆 45. / 63 Read more »

Bristol Myers' schizophrenia drug reduces symptoms without weight gain in late-stage studiesExplore stories from Atlantic Canada.
Source: SaltWire Network - 🏆 45. / 63 Read more »

Bristol Myers Beats on Revenue as Revlimid Sales Decline SlowsBristol Myers Squibb Co.’s first-quarter revenue beat Wall Street’s expectations as sales of the blockbuster cancer medicine Revlimid didn’t fall as quickly as analysts expected.
Source: BNNBloomberg - 🏆 83. / 50 Read more »

Bristol Myers posts quarterly loss, revenue rises 5%Explore stories from Atlantic Canada.
Source: SaltWire Network - 🏆 45. / 63 Read more »

Bristol Myers Squibb stock tumbles on cost-cutting initiativeBristol Myers Squibb (BMY) shares are trading lower Thursday afternoon following the pharmaceutical company's announcement of several cost-cutting...
Source: YahooFinanceCA - 🏆 47. / 63 Read more »

Cape Breton Hazmat volunteers 'blindsided' by dismissal, lockout by fire servicesExplore stories from Atlantic Canada.
Source: SaltWire Network - 🏆 45. / 63 Read more »